IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 863 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


TNFerade, an innovative cancer immunotherapeutic

Kali Arunava

Year : 2015| Volume: 47| Issue : 5 | Page no: 479-483

   This article has been cited by
1 Enhanced tumor inhibiting effect of 131I-BDI-1-based radioimmunotherapy and cytosine deaminase gene therapy modulated by a radio-sensitive promoter in nude mice bearing bladder cancer
Pan Hao, Chunli Zhang, Huan Ma, Rongfu Wang
Journal of Radiation Research. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Externally-Controlled Systems for Immunotherapy: From Bench to Bedside
María Tristán-Manzano, Pedro Justicia-Lirio, Noelia Maldonado-Pérez, Marina Cortijo-Gutiérrez, Karim Benabdellah, Francisco Martin
Frontiers in Immunology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
3 Nucleic Acid-Based Approaches for Tumor Therapy
Simone Hager, Frederic Julien Fittler, Ernst Wagner, Matthias Bros
Cells. 2020; 9(9): 2061
[Pubmed]  [Google Scholar] [DOI]
4 The effects of tumor necrosis factor-a (TNF-a) rs1800629 and rs361525 polymorphisms on sepsis risk
Yixin Zhang, Xiaoteng Cui, Li Ning, Dianjun Wei
Oncotarget. 2017; 8(67): 111456
[Pubmed]  [Google Scholar] [DOI]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow